Issue 83, 2018

Beta-galactosidase-responsive synthetic biomarker for targeted tumor detection

Abstract

Tumor biomarkers are highly desirable for the screening of patients with a risk of tumor development and progression. Here, we report a beta-galactosidase (β-gal)-responsive acetaminophen (β-GR-APAP) as a synthetic plasma biomarker for targeted tumor detection. Tumor β-gal labeling via the recognition of tumor-related antigen enabled the detection of a tumor using β-GR-APAP.

Graphical abstract: Beta-galactosidase-responsive synthetic biomarker for targeted tumor detection

Supplementary files

Article information

Article type
Communication
Submitted
26 Jul 2018
Accepted
17 Sep 2018
First published
26 Sep 2018

Chem. Commun., 2018,54, 11745-11748

Author version available

Beta-galactosidase-responsive synthetic biomarker for targeted tumor detection

T. Nishihara, S. Kuno, H. Nonaka, S. Tabata, N. Saito, S. Fukuda, M. Tomita, S. Sando and T. Soga, Chem. Commun., 2018, 54, 11745 DOI: 10.1039/C8CC06068A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements